| A potent, selective CBX2 chromodomain ligand and its cellular activity during prostate cancer neuroendocrine differentiation S Wang, A Alpsoy, S Sood, SC Ordonez‐Rubiano, A Dhiman, Y Sun, ... ChemBioChem 22 (13), 2335-2344, 2021 | 30 | 2021 |
| Selective and cell-active PBRM1 bromodomain inhibitors discovered through NMR fragment screening S Shishodia, R Nuñez, BP Strohmier, KL Bursch, CJ Goetz, MD Olp, ... Journal of medicinal chemistry 65 (20), 13714-13735, 2022 | 11 | 2022 |
| Polycomb group proteins in cancer: multifaceted functions and strategies for modulation S Wang, S C. Ordonez-Rubiano, A Dhiman, G Jiao, BP Strohmier, ... NAR cancer 3 (4), zcab039, 2021 | 9 | 2021 |
| Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer SC Ordonez-Rubiano, CA Maschinot, S Wang, S Sood, ... Journal of Medicinal Chemistry 66 (16), 11250-11270, 2023 | 3 | 2023 |
| DEVELOPMENT OF TOOLS TO UNDERSTAND THE ROLE OF THE PBAF CHROMATIN REMODELER IN PROSTATE CANCER SC Ordonez Rubiano Purdue University Graduate School, 2024 | | 2024 |
| SWI/SNF chromatin remodelers in prostate cancer progression SC Ordonez-Rubiano, BP Strohmier, S Sood, EC Dykhuizen Frontiers in Epigenetics and Epigenomics 1, 1337345, 2024 | | 2024 |
| Design and Synthesis of Bi‐aryl Methylated Lactam Derivatives to Inhibit the BRD7 Bromodomain Function in Prostate Cancer SC Ordonez‐Rubiano, C Maschinot, E Dykhuizen The FASEB Journal 36, 2022 | | 2022 |
